Notification of Interim Results

RNS Number : 3963M

Futura Medical PLC

15 August 2011

 



For immediate release

15 August 2011

Futura Medical plc

("Futura" or "the Company")

Notification of Interim Results

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that it will issue its interim results for the six months ended 30 June 2011 on Tuesday 27 September 2011.

A meeting for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan Communications, 107 Cheapside, London, EC2V 6DN.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Jessica Fontaine	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NOREASPSFEFFEFF